Evidence map›Paper›PMID 41088295›Full record

ArticleEpigenetics & chromatin2025

Optimizing genetic ancestry adjustment in DNA methylation studies: a comparative analysis of approaches.

Kira D Höffler, Seyma Katrinli, Matthew W Halvorsen, Anne-Kristin Stavrum, Kevin S O'Connell, Alexey Shadrin, Srdjan Djurovic, Ole A Andreassen, James J Crowley, Jan Haavik and 8 more

Abstract readComparative Study
In one paragraph

Article in Epigenetics & chromatin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Kira D HöfflerDepartment for Clinical Science, University of Bergen, Bergen, Norway. kira.hoeffler@uib.no.
Seyma KatrinliDepartment of Gynecology and Obstetrics, Emory University, Atlanta, GA, USA.
Matthew W HalvorsenDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Anne-Kristin StavrumDepartment for Clinical Science, University of Bergen, Bergen, Norway.
Kevin S O'ConnellCenter for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Alexey ShadrinCenter for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Srdjan DjurovicCenter for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ole A AndreassenCenter for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
James J CrowleyDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jan HaavikBergen Center for Brain Plasticity, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Kristen HagenBergen Center for Brain Plasticity, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Gerd KvaleDepartment of Clinical Psychology, University of Bergen, Bergen, Norway.
Kerry ResslerDepartment of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Bjarne HansenBergen Center for Brain Plasticity, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Jair C SoaresFaillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Gabriel R FriesFaillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Alicia K SmithDepartment of Gynecology and Obstetrics, Emory University, Atlanta, GA, USA.
Stéphanie Le HellardDepartment for Clinical Science, University of Bergen, Bergen, Norway. stephanie.lehellard@uib.no.

Funding

Deciphering the role of neuronal and peripheral DNA methylation in suicide and bipolar disorderK01MH121580 · NIMH · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FRIES, GABRIEL RODRIGO · 2020 to 2023
$699k
NIMH NIH HHS K01 MH121580
6 · The paper itself

Abstract

backgroundGenetic ancestry is an important factor to account for in DNA methylation studies because genetic variation influences DNA methylation patterns. One approach uses principal components (PCs) calculated from CpG sites that overlap with common SNPs to adjust for ancestry when genotyping data is not available. However, this method does not remove technical and biological variations, such as sex and age, prior to calculating the PCs. The first PC is therefore often associated with factors other than ancestry.

methodsWe developed and adapted the adapted EpiAnceR+ approach, which includes (1) residualizing the CpG data overlapping with common SNPs for control probe PCs, sex, age, and cell type proportions to remove the effects of technical and biological factors, and (2) integrating the residualized data with genotype calls from the SNP probes (commonly referred to as rs probes) present on the arrays, before calculating PCs and evaluated the clustering ability and relationship to genetic ancestry.

resultsThe PCs generated by EpiAnceR+ led to improved clustering for repeated samples from the same individual and stronger associations with genetic ancestry groups predicted from genotype information compared to the original approach. EpiAnceR+ also outperformed the use of DNA methylation PCs or surrogate variables for ancestry adjustment.

conclusionsWe show that the EpiAnceR+ approach improves the adjustment for genetic ancestry in DNA methylation studies. EpiAnceR+ can be integrated into existing R pipelines for commercial methylation arrays, such as 450 K, EPIC v1, and EPIC v2. The code is available on GitHub ( https://github.com/KiraHoeffler/EpiAnceR ).

Indexed as

DNA MethylationCpG IslandsFemaleGenotypeHumansMalePolymorphism, Single NucleotidePrincipal Component AnalysisAncestryDNA methylationEpigeneticsEWASMWAS

Identifiers

PMID41088295
PMCPMC12522430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.